| Study | Intervention name | Results | Unit of analysis | Time point | Type of assay | Population | ||
| GMT (95% CI) | GMR (95% CI) | |||||||
| COVID‐19 vaccine versus placebo | ||||||||
|
Keech 2020 |
NVX‐CoV2373 | 1984.20 (1405.80 to 2800.70) | 18.08 (12.18 to 26.85) | EU/mL | Day 21 after 1st dose | ELISA RBD‐binding IgG |
18–59 years | |
| Placebo | 109.70 (90.40 to 133.20) | |||||||
|
Formica 2021 |
NVX‐CoV2373 | 44,420.90 (37,929.10 to 52,023.80) | 352.26 (290 to 427.89) | EU/mL | Day 35 (14 days after the 2nd dose) |
ELISA | 18–84 years | |
| Placebo | 126.10 (114 to 139.40) | |||||||
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.